Alembic Pharmaceuticals informs about press release

26 Dec 2022 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. The company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

664.00 -11.75 (-1.74%)
19-Mar-2026 13:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1763.00
Dr. Reddys Lab 1271.55
Cipla 1244.90
Zydus Lifesciences 881.25
Lupin 2262.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×